Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | USRM | Common Stock | Other | $8.67K | +1.45M | +4.69% | $0.01 | 32.3M | Apr 1, 2020 | Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director | F1 |
transaction | USRM | Common Stock | Other | $9.16K | +2.04M | +6.12% | $0.00 | 35.3M | Oct 5, 2020 | Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director | F1 |
transaction | USRM | Common Stock | Other | $9.13K | +188K | +0.53% | $0.05 | 35.5M | Apr 2, 2021 | Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director | F1 |
holding | USRM | Common Stock | 1.68M | Apr 1, 2020 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | USRM | Convertible promissory Note (right to buy) | Award | $376B | +3.76M | +103.71% | $100,000.00* | 7.38M | Feb 17, 2021 | Common Stock | 3.76M | $0.03 | Direct |
Id | Content |
---|---|
F1 | Interest payment on outstanding debt. |